Logo image of MARK

REMARK HOLDINGS INC (MARK) Stock Fundamental Analysis

NASDAQ:MARK - Nasdaq - US75955K3005 - Common Stock - Currency: USD

0.421  -0.08 (-15.19%)

After market: 0.42 0 (-0.24%)

Fundamental Rating

0

MARK gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. Both the profitability and financial health of MARK have multiple concerns. MARK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MARK has reported negative net income.
MARK had a negative operating cash flow in the past year.
MARK had negative earnings in 4 of the past 5 years.
In the past 5 years MARK always reported negative operating cash flow.
MARK Yearly Net Income VS EBIT VS OCF VS FCFMARK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

MARK has a worse Return On Assets (-240.32%) than 96.38% of its industry peers.
Industry RankSector Rank
ROA -240.32%
ROE N/A
ROIC N/A
ROA(3y)-156.68%
ROA(5y)-133.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MARK Yearly ROA, ROE, ROICMARK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 1K

1.3 Margins

MARK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MARK Yearly Profit, Operating, Gross MarginsMARK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

MARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MARK has less shares outstanding
MARK has a worse debt/assets ratio than last year.
MARK Yearly Shares OutstandingMARK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
MARK Yearly Total Debt VS Total AssetsMARK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

MARK has an Altman-Z score of -53.58. This is a bad value and indicates that MARK is not financially healthy and even has some risk of bankruptcy.
MARK's Altman-Z score of -53.58 is on the low side compared to the rest of the industry. MARK is outperformed by 96.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -53.58
ROIC/WACCN/A
WACC12.8%
MARK Yearly LT Debt VS Equity VS FCFMARK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M

2.3 Liquidity

A Current Ratio of 0.23 indicates that MARK may have some problems paying its short term obligations.
MARK's Current ratio of 0.23 is on the low side compared to the rest of the industry. MARK is outperformed by 97.83% of its industry peers.
A Quick Ratio of 0.22 indicates that MARK may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, MARK is not doing good in the industry: 97.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.22
MARK Yearly Current Assets VS Current LiabilitesMARK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for MARK have decreased strongly by -178.75% in the last year.
MARK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -64.51%.
Measured over the past years, MARK shows a very negative growth in Revenue. The Revenue has been decreasing by -30.23% on average per year.
EPS 1Y (TTM)-178.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-387.5%
Revenue 1Y (TTM)-64.51%
Revenue growth 3Y32.47%
Revenue growth 5Y-30.23%
Sales Q2Q%-93.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MARK Yearly Revenue VS EstimatesMARK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
MARK Yearly EPS VS EstimatesMARK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 -5 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MARK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MARK Price Earnings VS Forward Price EarningsMARK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MARK Per share dataMARK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MARK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REMARK HOLDINGS INC

NASDAQ:MARK (2/13/2024, 8:00:01 PM)

After market: 0.42 0 (-0.24%)

0.421

-0.08 (-15.19%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-20 2023-11-20/amc
Earnings (Next)04-15 2024-04-15/amc
Inst Owners0.47%
Inst Owner Change0%
Ins Owners22.51%
Ins Owner Change0%
Market Cap8.81M
Analysts82.86
Price TargetN/A
Short Float %0.23%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0.28
BVpS-1.57
TBVpS-1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -240.32%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-156.68%
ROA(5y)-133.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 160.87%
Cap/Sales 6.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.22
Altman-Z -53.58
F-Score3
WACC12.8%
ROIC/WACCN/A
Cap/Depr(3y)365.86%
Cap/Depr(5y)228.05%
Cap/Sales(3y)5.72%
Cap/Sales(5y)10.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-178.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-387.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-64.51%
Revenue growth 3Y32.47%
Revenue growth 5Y-30.23%
Sales Q2Q%-93.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.58%
OCF growth 3YN/A
OCF growth 5YN/A